Spectrum pharmaceuticals investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of spectrum pharmaceuticals, inc. - sppi

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of spectrum pharmaceuticals, inc. (nasdaqgs: sppi) to assertio holdings, inc. (nasdaqcm: asrt). under the terms of the proposed transaction, shareholders of spectrum will receive, for each share of spectrum that they own, 0.1783 shares of assertio and one contingent value right for the right to receive $0.10 paya.
ASRT Ratings Summary
ASRT Quant Ranking